Detalhe da pesquisa
1.
TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.
World J Surg Oncol
; 20(1): 336, 2022 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207751